Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Citi
QuintilesIMS
AstraZeneca
Healthtrust
Moodys
Deloitte
Mallinckrodt

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,692,825

« Back to Dashboard

Title: INDANYL ACETIC ACIDS
Abstract:Process for preparing 1-benzylidene-5-fluoro-3-indenyl acetic acids by 2,3-dehydrogenating a 1-benzylidene-3-indanyl acetic acid. Also included are novel 1-benzylidene-3-indanyl acetic acid intermediates.
Inventor(s): Conn; John B. (Westfield, NJ)
Assignee:
Filing Date:May 01, 1970
Application Number:05/033,893
Claims:1. 5-Fluoro-2-methyl-1-(p-methylsulfinylbenzyl-idene)-3-indanyl acetic acid.

2. The cis-isomer of a compound as in claim 1.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Healthtrust
Dow
Medtronic
Harvard Business School
Federal Trade Commission
US Department of Justice
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.